Trevi Therapeutics (TRVI) Cash from Operations Growth (3y) (2021 - 2026)
Trevi Therapeutics (TRVI) Cash from Operations Growth (3y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
37.40% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
16.64% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Trevi Therapeutics |
2.08 Bn |
1.91 Bn |
- |
-26.74% |
| Date | Value |
|---|
| Mar 31, 2026 |
-26.74% |
| Dec 31, 2025 |
-6.42% |
| Sep 30, 2025 |
-8.26% |
| Jun 30, 2025 |
-17.82% |
| Mar 31, 2025 |
-23.86% |
| Dec 31, 2024 |
-15.31% |
| Sep 30, 2024 |
-9.69% |
| Jun 30, 2024 |
-3.21% |
| Mar 31, 2024 |
-11.37% |
| Dec 31, 2023 |
10.68% |
| Sep 30, 2023 |
-1.47% |
| Jun 30, 2023 |
-5.39% |
| Mar 31, 2023 |
-20.60% |
| Dec 31, 2022 |
-0.69% |
| Sep 30, 2022 |
-3.50% |
| Jun 30, 2022 |
-6.86% |
| Mar 31, 2022 |
-20.08% |
| Dec 31, 2021 |
-9.60% |
| Sep 30, 2021 |
-21.95% |
| Jun 30, 2021 |
-12.08% |
